✦ LIBER ✦

Comparison of bronchodilatory properties of transdermal and inhaled long-acting β2-agonists

✍ Scribed by T. Yamagata; T. Hirano; H. Sugiura; S. Yanagisawa; T. Ichikawa; K. Ueshima; K. Akamatsu; M. Nakanishi; K. Matsunaga; Y. Minakata; M. Ichinose

Book ID: 116853359
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 177 KB
Volume: 21
Category: Article
ISSN: 1094-5539
DOI: 10.1016/j.pupt.2007.05.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cough and transdermal long-acting β2 ago

Cough and transdermal long-acting β2 agonist in Japan

✍ Satoru Ebihara; Takae Ebihara; Hiroyuki Arai 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Compliance with inhaled glucocorticoids

Compliance with inhaled glucocorticoids and concomitant use of long-acting β2-agonists

✍ H.J. VAN DER WOUDE; R. AALBERS 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Comparison of the Bronchodilator Effect

Comparison of the Bronchodilator Effect of Inhaled Short- and Long- Acting β2- Agonists in Children with Bronchial Asthma

✍ Dr Marcello Verini, Alberto Verrotti, Rita Greco, Francesco Chiarelli 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 258 KB

Clinical outcome of adding long-acting β

Clinical outcome of adding long-acting β-agonists to inhaled corticosteroids

✍ P.J. Barnes 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Benefits of long-acting β2-agonists

✍ Lipworth, Brian J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Characteristics of users of inhaled long

Characteristics of users of inhaled long-acting β2-agonists in a Southern European population

✍ J. Castellsague; L.A. Garcia-Rodríguez; S. Pérez-Gutthann; L. Agostinis; C. Catt 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 680 KB